Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPSE | Q9Y251 | 7/20 | 0.34 |
| ▸ | FGF1 | P05230 | 3/20 | 0.34 |
| ▸ | FGF2 | P09038 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17122692 | 0.95 | HPSE (0.32) | HPSEFGF1FGF2 | |
| SCHEMBL16018205 | 0.93 | MDK (0.34) | HPSEFGF1FGF2 | |
| SCHEMBL16905450 | 0.93 | HPSE (0.33) | HPSEFGF1FGF2MAPK1 | |
| SCHEMBL16250407 | 0.92 | HPSE (0.34) | HPSEFGF1FGF2MAPK1CA1 | |
| SCHEMBL16905487 | 0.89 | GJB2 (0.36) | HPSEFGF1FGF2MAPK1 | |
| SCHEMBL16846651 | 0.88 | — | — | |
| SCHEMBL16299805 | 0.88 | HPSE (0.39) | HPSEFGF1FGF2 | |
| SCHEMBL16299812 | 0.88 | MDK (0.32) | HPSEFGF1FGF2 | |
| SCHEMBL16299810 | 0.88 | HPSE (0.37) | HPSEFGF1FGF2MAPK1CA1 | |
| SCHEMBL15833445 | 0.88 | HPSE (0.35) | HPSEFGF1FGF2MAPK1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150196655-A1 | CARBOHYDRATE CONJUGATED RNA AGENTS AND PROCESS FOR THEIR PREPARATION | BANK OF AMERICA, N.A. | 2015-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150196655-A1 | CARBOHYDRATE CONJUGATED RNA AGENTS AND PROCESS FOR THEIR PREPARATION | RNASE1, IGF2BP1, IGF2BP2 | HPSE 379/4885FGF1 4045/4885FGF2 3358/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.